Table 1.

Results of virologic investigations of the 3 SARS-CoV-2–positive blood donations

No. of donationDetection by rtPCR on neat plasma, n positive/n tested (Ct)Detection by rtPCR after UC, n positive/n tested (Ct)RT-PCR/sequencingVirus culture
R-GENE PCR1*R-GENE PCR2*NRC rtPCRR-GENE PCR1R-GENE PCR2
NCRdPdERdPd target 1RdPd target 2NCRdPdEPlasmaAfter UCPlasmaAfter i-UC
POS 1/1 (37.9) NEG 0/1 NEG 0/1 NEG 0/4 Pos 2/4 (37.0; 37.1) POS 1/1 (35.3) POS 1/1 (41.6) NEG O/1 NEG POS 1/1 NEG NEG 
POS 1/1 (37.5) NEG 0/1 NEG 0/1 POS 1/3 (39.3) POS 1/3 (37.4) POS 1/2 (37.0) NEG 0/2 NEG 0/1 NEG POS 1/2 NEG NEG 
POS 1/1 (38.0) NEG 0/1 POS 1/1 (38.4) NEG 0/2 NEG 0/2 POS 1/2 (38.3) NEG 0/2 POS 1/1 (42.2) NEG NEG 0/2 NEG NEG 
No. of donationDetection by rtPCR on neat plasma, n positive/n tested (Ct)Detection by rtPCR after UC, n positive/n tested (Ct)RT-PCR/sequencingVirus culture
R-GENE PCR1*R-GENE PCR2*NRC rtPCRR-GENE PCR1R-GENE PCR2
NCRdPdERdPd target 1RdPd target 2NCRdPdEPlasmaAfter UCPlasmaAfter i-UC
POS 1/1 (37.9) NEG 0/1 NEG 0/1 NEG 0/4 Pos 2/4 (37.0; 37.1) POS 1/1 (35.3) POS 1/1 (41.6) NEG O/1 NEG POS 1/1 NEG NEG 
POS 1/1 (37.5) NEG 0/1 NEG 0/1 POS 1/3 (39.3) POS 1/3 (37.4) POS 1/2 (37.0) NEG 0/2 NEG 0/1 NEG POS 1/2 NEG NEG 
POS 1/1 (38.0) NEG 0/1 POS 1/1 (38.4) NEG 0/2 NEG 0/2 POS 1/2 (38.3) NEG 0/2 POS 1/1 (42.2) NEG NEG 0/2 NEG NEG 

E, envelope protein; Ct, cycle threshold; i-UC, ultracentrifugation on iodixanol pad (10.5 mL plasma); NEG, negative; NC, nucleocapsid gene; POS, positive; RdPd, polymerase gene; UC, ultracentrifugation (12 mL plasma).

*

SARS-COV-2 R-GENE assay (BioMérieux).

rtPCR from the National Reference Center for respiratory viruses (NCR rt-PCR, Pasteur Institute).

RT-PCR primers: 5′-GCT​TTT​CAA​ACT​GTC​AAA​CC-3′ and 5′-GGT​GAG​GGT​TTT​CTA​CAT​CA-3′; hemi-nested PCR primers: 5′-TGC​TGT​GTC​TAA​GGG​TTT​CT-3′ and 5′-GGT​GAG​GGT​TTT​CTA​CAT​CA-3′.

Close Modal

or Create an Account

Close Modal
Close Modal